This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Aptatargets
<
BACK TO THE PORTFOLIO
Strategy
Life Science
Fund
Inveready Biotech II/ Inverady Biotech III
Year Invested
2017
Status
Exited
Website
Clinical-stage company focused in developing therapeutic applications based in aptamer technology.The lead-candidate is a neuroprotective drug for acute ischemic stroke by targeting inflammation in the acute phase, the company has completed the phase IIa recruiting.